Biosimilars play a critical role in lowering drug prices. Kaiser Permanente successfully uses biosimilars to improve affordability for our members. We are eager to share best practices and work with policymakers to help facilitate a more competitive market for biologic drugs in the United States.
Last month I had an opportunity to speak at a Kaiser Permanente Institute for Health Policy forum and it sparked an important conversation about the power and potential risks of telehealth. The field has advanced in many ways over the last…
